{{Rsnum
|rsid=10932029
|Gene=ICOS
|Chromosome=2
|position=203937045
|Orientation=plus
|GMAF=0.1028
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ICOS,LOC101927840
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 23.0 | 76.1
| HCB | 0.7 | 15.3 | 83.9
| JPT | 0.0 | 25.7 | 74.3
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.7 | 15.3 | 83.9
| CHD | 0.9 | 24.8 | 74.3
| GIH | 2.0 | 37.6 | 60.4
| LWK | 0.0 | 0.9 | 99.1
| MEX | 3.4 | 20.7 | 75.9
| MKK | 0.0 | 5.8 | 94.2
| TSI | 2.9 | 25.5 | 71.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=21526489
|Title=ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population
}}

{{PMID Auto
|PMID=21917182
|Title=ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study
|OA=1
}}

{{PMID Auto
|PMID=19014504
|Title=Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms.
|OA=1
}}

{{PMID Auto
|PMID=19672595
|Title=Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}